Vivani Medical Inc. (VANI)
Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026
RenovoRx Inc. (RNXT)
RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer
CELCUITY INC. (CELC)
Celcuity To Participate in Upcoming Investor Conferences
ACLARIS THERAPEUTICS, INC. (ACRS)
Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
BLUE GOLD LTD (BGL)
Blue Gold Appoints Capital Markets Veteran as Chief Financial Officer
LEXICON PHARMACEUTICALS, INC. (LXRX)
Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
RENOVORX, INC. (RNXT)
RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer
CINTAS CORP (CTAS)
Cintas Earns Newsweek’s Most Trustworthy Companies in America 2026 Award
COLUMBUS MCKINNON CORP (CMCO)
Columbus McKinnon to Present at Upcoming Wells Fargo Industrials & Materials Conference
POLARYX THERAPEUTICS, INC. (PLYX)
Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial